What is CG Oncology's financing cash flow?

CG Oncology (CGON) reported financing cash flow of $393M in Q1 2026.

How has CG Oncology's financing cash flow changed year-over-year?

CG Oncology's financing cash flow increased by 87232.9% year-over-year, from $450K to $393M.

What is the long-term trend for CG Oncology's financing cash flow?

Over 2 years (2023 to 2025), CG Oncology's financing cash flow has grown at a 30.8% compound annual growth rate (CAGR), from $89.89M to $153.89M.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

CG Oncology CGON Financing Cash Flow

Financing Cash Flow at other companies

PfizerPFE

-$2.86B+45.4%

Johnson & JohnsonJNJ

$530M-94.9%

Gilead SciencesGILD

-$4.24B-23.7%

ImmunityBio, Inc.IBRX

$223.93M+22,903%

Cogent Biosciences, Inc.COGT

$52.54M+110%

Tango TherapeuticsTNGX

$79.85M+3,992,200%

Other financials

Income statement

See full

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

Net income-$60.2M-74.7%

EPS (diluted)-$0.71-57.8%

Balance sheet

See full

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

See full

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

See full

Market cap$5.39B+206%

Profitability

See full

Operating margin-4,239%-1,872pp

Net margin-3,682.6%-1,601pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

See full

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Current ratio31.3×+0.3×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CG Oncology's financing cash flow?: CG Oncology (CGON) reported financing cash flow of $393M in Q1 2026.
How has CG Oncology's financing cash flow changed year-over-year?: CG Oncology's financing cash flow increased by 87232.9% year-over-year, from $450K to $393M.
What is the long-term trend for CG Oncology's financing cash flow?: Over 2 years (2023 to 2025), CG Oncology's financing cash flow has grown at a 30.8% compound annual growth rate (CAGR), from $89.89M to $153.89M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.